Slovakia Pharmaceuticals & Healthcare Report Q2 2018
Expenditure within Slovakia's pharmaceutical market will come under increasing scrutiny as healthcare funding remainsinsufficient. Increased rhetoric towards the use of OTC medicines and enforcement of generic substitution policies will limitpatented drugmaker opportunities, leading to underperformance relative to its neighbours. This all means revenue challenges formultinational pharmaceutical firms.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook